Skip to Main Content

1,264

Views

2

CrossRef citations to date

0

Altmetric

Articles

Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting

Bruce Strobera Department of Dermatology, Yale University, New Haven, CT, USA;b Department of Dermatology, Central Connecticut Dermatology Research, Cromwell, CT, USACorrespondence[email protected]

https://orcid.org/0000-0002-8394-2057 View further author information

,

Dhaval Patilc Department of Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information

,

Robert R. McLeand Department of Epidemiology, CorEvitas, LLC, Waltham, MA, USAView further author information

,

Melissa Moore-Clingenpeele Department of Biostatistics, CorEvitas, LLC, Waltham, MA, USAView further author information

,

Ning Guoe Department of Biostatistics, CorEvitas, LLC, Waltham, MA, USAView further author information

,

Eugenia Levif Department of Dermatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information

&

Mark Lebwohlg Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information